Medical and Supplement Use and Peripheral Neuropathies

Dworkin, 2010, Recommendations for the pharmacological management of neuropathic pain: an overview and literature update, Mayo Clin Proc, 85, S3, 10.4065/mcp.2009.0649 Pop-Busui, 2017, Diabetic neuropathy: a position statement by the American Diabetes Association, Diabetes Care, 40, 136, 10.2337/dc16-2042 Zilliox, 2017, Neuropathic pain, Continuum, 23, 512 Hoffman, 2017, Association of long-term opioid therapy with functional status, adverse outcomes, and mortality among patients with polyneuropathy, JAMA Neurol, 74, 773, 10.1001/jamaneurol.2017.0486 Brami, 2016, Natural products and complimentary therapies for chemotherapy-induced peripheral neuropathy: A systematic review, Crit Rev Oncol Hematol, 98, 325, 10.1016/j.critrevonc.2015.11.014 Dy Schloss, 2013, Nutraceuticals and chemotherapy induced peripheral neuropathy (CIPN): A systematic review, Clin Nutr, 32, 888, 10.1016/j.clnu.2013.04.007 Desideri, 2017, Use of an alpha lipoic, methylsulfonylmethane and bromelain dietary supplement (Opera) for chemotherapy-induced peripheral neuropathy management, a prospective study, Med Oncol, 34, 46, 10.1007/s12032-017-0907-4 Tofthagen, 2018, (2018). Starting a free, nurse-led, multi-disciplinary clinic for adults with peripheral neuropathy, Nursing, 48, 39, 10.1097/01.NURSE.0000541387.44481.a7 Brayall, 2018, Physical therapy-based interventions improve balance, function, symptoms, and quality of life in patients with chemotherapy-induced peripheral neuropathy: a systematic review, Rehab Oncol, 36, 161 Dinicola, 2018, Natural products—alpha-lipoic acid and acetyl-L-carnitine—in the treatment of chemotherapy-induced peripheral neuropathy, Eur Rev Med Pharmacol Sci, 22, 4739 Hershman, 2014, Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guide, J Clin Oncol, 32, 1941, 10.1200/JCO.2013.54.0914